✨
AI Summary
- Tahir Amin of I-MAK discusses how patent monopolies hinder drug competition.
- The current IP system limits access to off-patent drugs globally.
- This impacts global health equity and the availability of affordable medicines.
Guests on This Episode
TA
Tahir Amin
1 podcast appearance